"Designing Growth Strategies is in our DNA"

Antimicrobial Susceptibility Testing Market Size, Share, and COVID-19 Impact Analysis, By Test Type (Antibacterial Testing, Antifungal Testing, and Others), By Method (E-TEST, Disks Diffusion, Rapid Automation Method, and Others), By Application (Diagnostics, Drug Discovery & Development, and Others), By End-Users (Hospitals & Clinics, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, and Others), and Regional Forecast, 2024-2032

Region :Global | Report ID: FBI107735 | Status : Ongoing



Antimicrobial susceptibility testing (AST) is a procedure performed to identify an appropriate antimicrobial regimen that is specifically effective for individual patients. The specimens used for culture and sensitivity tests are blood, urine, cerebrospinal fluid, sputum, wound, stool, and other body fluids and discharge. There are various types of infections such as skin infections, respiratory tract infections, sexually transmitted diseases, and urinary tract infections, which demand appropriate regimens for treatment.

  • For instance, according to data published by WHO, in November 2022, pneumonia accounted for 14% of death of children under five years of age. Around 740,180 deaths of children occurred in 2019 were reported due to pneumonia, and the main cause of developing pneumonia are bacteria, viruses, and fungi.

  • For instance, according to data published by WHO in April 2023, tuberculosis (T.B). is the 13th leading cause of death worldwide. In 2021, estimated 10.6 million people were diagnosed with T.B. worldwide. A total of 6 million men, 3.4 million women, and 1.2 million children were affected by T.B.

The phenomenon known as antimicrobial resistance (AMR) occurs when bacteria, viruses, fungi, and parasites change or no longer respond to medicines making infections more difficult to treat and increasing the risk of death due to disease spread. AMR is a global health threat due to the increasing emergence and spread of drug-resistant pathogens that have acquired new resistance mechanisms, leading to antimicrobial resistance. It continues to threaten the human body's ability to treat common infections.

  • For instance, according to data published by WHO in November 2021, AMR is one of the world's top 10 public health threats to humanity. Modern medicine's success in treating infection, including during major surgery and cancer chemotherapy, would have been at risk without effective antimicrobials.

The use of antimicrobial susceptibility testing is increasing due to an increase in certain conditions such as pneumonia, sepsis, meningitis, and T.B. The increasing resistance to antimicrobial treatment is the one of key drivers supporting the growth of the antimicrobial susceptibility testing market.

Impact of COVID-19 on the Antimicrobial Susceptibility Testing Market

The antimicrobial susceptibility testing market witnessed a slightly positive impact of the COVID-19 pandemic in 2020 due to increased antimicrobial resistance to antibiotic therapy.

  • For instance, as per the article published in September 2021 by Annals of Clinical Microbiology and Antimicrobials under the title "Antimicrobial susceptibility patterns of respiratory Gram-negative bacterial isolates from COVID-19 patients in Switzerland." The bacterial superinfections were developed in ventilated COVID-19 patients highly impacted by antimicrobial resistance. In some cases, continuous modification of antibiotic therapy was needed.

The demand for antimicrobial susceptibility testing increased due to increased antimicrobial resistance associated with COVID-19 cases, which resulted in the growth of the Antimicrobial susceptibility testing Market.

Key Insights

The following key insights will be covered in the report:

  • Prevalence of Microbial Infections - by Key Countries/Regions, 2022.

  • Pricing Analysis, Key Products / Key Players, 2022.

  • Overview of Regulatory Scenario - by Key Countries/Regions.

  • Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.).

  • Impact of COVID-19 on the Antimicrobial Susceptibility Testing Market.

Analysis by Application

Based on application, the drug discovery & development segment accounted for a significant proportion of the Antimicrobial Susceptibility Testing market in 2022. The growth is mainly attributed to the constant innovation and the development of new therapeutic products to treat highly prevalent infectious diseases.

  • For instance, in March 2023, as per the article published by Elsevier B.V. on behalf of King Saud University, most of the genotypic methods are being used for drug discovery, resistance monitoring, or research, and at present, non-phenotypic methods like nucleic acid or nanotechnology-based ASTs are mostly intended for the drug discovery or research.

Regional Analysis

To gain extensive insights into the market, Request for Customization

North America is anticipated to gain a significant market share in the antimicrobial susceptibility testing market during the forecast period. The key factors driving the market's growth are the rising prevalence of microbial infections, the availability of technologically advanced diagnostic tests, and a well-established regional healthcare infrastructure. The increasing incidence of multidrug-resistant organisms and growing demand for precision medicine are some other factors boosting market growth.

  • For instance, according to the report published by CDC in 2022, each year, 2.8 million antimicrobial-resistant infections occur in the United States, and as a result, more than 35,000 people die.

 The increased incidence of multidrug-resistant organisms and growing demand for precision medicine are the primary factors boosting market growth.

Key Players Covered

The report will include key players' profiles, such as Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Bruker, F. Hoffmann-La Roche Ltd., and HiMedia Laboratories. 


By Test Type

By Method

By Application

By End-Users

By Geography

  • Antibacterial Testing

  • Antifungal Testing

  • Others

  • E-TEST

  • Disks Diffusion

  • Rapid Automation Method

  • Others

  • Diagnostics

  • Drug Discovery & Development

  • Others

  • Hospitals & Clinics

  • Clinical Laboratories

  • Pharmaceutical & Biotechnology Companies

  • Others

  • North America (U.S. and Canada)

  • Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and the Rest of Europe)

  • Asia Pacific (Japan, China, Australia, India, Southeast Asia, and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, and Rest of Latin America

  • Middle East & Africa (GCC, South Africa, and Rest of the Middle East and Africa)

Key Industry Developments

  • February 2023: bioMérieux S.A. launched MAESTRIA new generation microbiology software. This software has a state-of-the-art graphical user interface that covers various workflow steps, including staining results or manual input of offline Antimicrobial Susceptibility Testing (AST). This software helped the company reinforce its position in infectious disease diagnostics with cutting-edge technology, not only for testing but also for the management of the generated data

  • May 2022: Qualigen Therapeutics acquired a majority stake in the diagnostics technology company of NanoSynex. This acquisition is expected to help the company to leverage long-standing diagnostics development including Antimicrobial Susceptibility Testing (AST) platform, and regulatory and commercial expertise to expand its footprint as a diversified life sciences company.

  • April 2022: COPAN Diagnostics (Murrieta, CA, USA) showcased its range of fully automated solutions for identification and antimicrobial susceptibility testing (AST) in clinical microbiology at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022).

  • In October 2018, B.D. launched a molecular test for detecting tuberculosis and multidrug-resistant T.B. is an integrated diagnostic test used to detect and diagnose T.B. and INH- and RIF- resistance.

  • September 2017: Bruker announced the acquisition of MERLIN Diagnostika GmbH to add selected antibiotic resistance and susceptibility testing to its MALDI Biotyper, a microbial identification platform. This acquisition further expands Bruker's microbiology business based on rapid, broad-based microbial identification.

  • Ongoing
  • 2023
  • 2019-2022

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients


Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.